Smith Hunter C bought RYTM

March 2, 2026 · Form 4 insider transaction

Smith Hunter C bought 6,099 shares of Rhythm Pharmaceuticals, Inc. at $6.80 per share, a transaction worth $41.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.